Precision Business Insights has published a report on the global computer-aided drug discovery market, estimating its value at USD 4,150.9 Million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 9.1% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/computer-aided-drug-discovery-market
The computer-aided drug discovery (CADD) market refers to the use of advanced computational tools and algorithms to speed up and improve the drug development process. CADD uses techniques including molecular modeling, virtual screening, and quantitative structure-activity relationship (QSAR) research to simulate interactions between drug candidates and biological targets.
Drivers:
- Rising demand for faster drug development: CADD shortens discovery timelines and reduces R&D costs.
- Growth in precision medicine: CADD enables personalized drug design based on genetic and molecular profiles.
The global computer-aided drug discovery market segmentation:
1) By Type: Structure Based Drug Design, Ligand Based Drug Design, Sequence Based Drug Design
2) By Application: Oncology, Neurology, Cardiovascular Disease, Diabetes, Respiratory Disease, Others
3) By End-User: Pharmaceutical and Biotechnology Companies, Research Laboratories, Others
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=992892
Regional Overview:
The report also examines the current concerns and their Future Effects on the computer-aided drug discovery market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the computer-aided drug discovery market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
The competitive landscape is dominated by major players like Charles River Laboratories, Aris Pharmaceuticals Inc., BOC Sciences, BioDuro-Sundia, Bayer AG, AstraZeneca, Aragen Life Sciences Pvt. Ltd., Schrödinger, Inc., GenScript, BioNTech
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
